ATP1A2 and Coma: FHM2 patients with the G301R mutation resulting from a gene variant in the ATP1A2 gene have migraine comorbidity with epilepsy, coma, motor symptoms and psychiatric disorders such as depression and obsessive–compulsive disorder (OCD)31,32.